Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solovo Research Institute, Columbus, Ohio, United States of America
*Corresponding Author: Shahanshah Khan, Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solovo Research Institute, Columbus, Ohio, United States of America.
Received: October 05, 2017; Published: January 09, 2018
Citation: Shahanshah Khan. “Melatonin as a Promising Radiation Countermeasure”. Acta Scientific Pharmaceutical Sciences 2.1 (2018).
The term radiation countermeasure targets drugs used for the prevention (radioprotectors), mitigation (radiomitigators) and treatment (therapeutics) of acute radiation injury. Also, radiation countermeasures are needed for the effective medical management of nuclear accidents, and for the deployment of emergency responders for the clean-up operations. In the present global perspectives nuclear/radiation fears arising due to catastrophic accidents due to natural or man-made disasters including threats from the rogue nations and terrorists organizations, several government agencies including Department of Atomic Energy (DAE), Defence Research and Development Organization (DRDO), Indian Council of Medical Research (ICMR), and many others have started radiation countermeasures program and prioritize it for the development of novel and non-toxic agents that can attenuate the deleterious side effects of ionizing radiation.
Copyright: © 2018 Shahanshah Khan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.